Corporate description Inveres...

Corporate description
Inveresk Research (NASDAQ: IRGI) is single of the world's leading providers of consequence development services to the pharmaceutical, biotechnology and medical device industries. The company's services include toxicology, laboratory sciences, international and regional clinical trials, and overall strategic planning and management end all phases of the remedy development and regulatory approval proces Inveresk is single of only a few CRO in the world with the ability and expertise to take a outcome from the laboratory through the clinical research phases to